ARS Pharmaceuticals Inc. stock rose Friday as FDA identified deficiencies in rival Aquestive's application, delaying ...
Detailed price information for Aquestive Therapeutics Inc (AQST-Q) from The Globe and Mail including charting and trades.
ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) is one of the 12 Stocks that Will Bounce Back According to Wall Street Analysts. On ...
Announces receipt of FDA letter stating it has identified deficiencies that preclude labeling discussions for Anaphylm at this time Receives confirmation from FDA that Agency's review of Anaphylm NDA ...
New Jersey, USA-based Aquestive Therapeutics saw its shares plummet nearly 48% to $3.25 (Nasdaq: AQST) pre-market today, ...
Aquestive Therapeutics shares fall after the FDA flags deficiencies in its Anaphylm allergy drug application, raising ...
Stocktwits on MSN
Why did AQST stock plunge 40% in pre-market today?
Shares of Aquestive Therapeutics (AQST) plunged 40% in pre-market trading on Friday after the company announced that it ...
Health system pharmacists and clinicians are monitoring a wave of drug approvals expected throughout 2026, including first-in-class therapies and expanded uses of existing drugs with implications for ...
The night included a live auction and cash call led by Tom Quick, whose Irish charm could coax a blank check from Ebeneezer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback